Posts Tagged:Tal Galit

Hadassah and Neurogenesis announce results from Phase 2 MS Study

by

A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof.…



Hadassah Hospital’s Stem Cell research results shows promise for a treatment for Progressive MS

by

Breaking news: The results of the latest M.S. research project study at Hadassah Hospitals in Jerusalem are just published in “Brain” Journal of Neurology by Oxford Academic. Hadassah UK is proud to have supported Multiple Sclerosis research at Hadassah by a team led by Prof. Dimitrios Karussis. Prof. Karussis’ team study is a culmination of…



DONATE NOW

Donate

£

Please enter above the amount you would like to donate

Personal Info

25% more with Gift Aid
Billing Details

Donation Total: £25.00

Contact Us

Hadassah UK
25 The Burroughs
Hendon, London
NW4 4AR
Tel: 0208 202 2860
Email: uk.office(at)hadassah.org.uk
Registered Charity No. 1040848
Terms, Conditions and Policies

Check us out on Facebook